BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16751698)

  • 1. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Biomarkers for cartilage matrix turnover and destruction in joint diseases].
    Kojima T
    Clin Calcium; 2006 Jun; 16(6):1009-15. PubMed ID: 16751698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of biomarker for detecting cartilage degradation in osteoarthritis].
    Kojima T; Ishiguro N
    Nihon Rinsho; 2012 May; 70(5):796-801. PubMed ID: 22620003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy.
    Jansen NW; Roosendaal G; Lundin B; Heijnen L; Mauser-Bunschoten E; Bijlsma JW; Theobald M; Lafeber FP
    Arthritis Rheum; 2009 Jan; 60(1):290-8. PubMed ID: 19116938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of cartilage turnover. Part 2: Non-collagenous markers.
    Garvican ER; Vaughan-Thomas A; Clegg PD; Innes JF
    Vet J; 2010 Jul; 185(1):43-9. PubMed ID: 20488734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biochemical markers in cartilage injury and repair].
    Taşkiran D
    Acta Orthop Traumatol Turc; 2007; 41 Suppl 2():6-12. PubMed ID: 18180578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone sialoprotein in laboratory diagnostic work-up of osteoarthritis.
    Lis K
    Ortop Traumatol Rehabil; 2008; 10(3):211-7. PubMed ID: 18552758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research progress of biomarker COMP in osteoarthritis].
    Zhu TH; Cai CY; Zhang L
    Zhongguo Gu Shang; 2010 Dec; 23(12):959-61. PubMed ID: 21265214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemical markers of bone turnover. New aspect. Biomarkers of cartilage metabolism].
    Okano T; Koike T
    Clin Calcium; 2009 Aug; 19(8):1149-58. PubMed ID: 19638699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of moving training on histology and biomarkers levels of articular cartilage.
    Qi C; Changlin H
    J Surg Res; 2006 Oct; 135(2):352-63. PubMed ID: 16904690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic markers of arthritis.
    Scher DM; Stolerman ES; Di Cesare PE
    Am J Orthop (Belle Mead NJ); 1996 Apr; 25(4):263-72. PubMed ID: 8728363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular markers of osteoarthritis].
    Senolt L; Pavelka K
    Acta Chir Orthop Traumatol Cech; 2005; 72(3):191-6. PubMed ID: 16105504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma inhibitory activity, a biomarker related to chondrocyte anabolism, is reversibly suppressed by proinflammatory cytokines in rheumatoid arthritis.
    Vandooren B; Cantaert T; van Lierop MJ; Bos E; De Rycke L; Veys EM; De Keyser F; Bresnihan B; Luyten FP; Verdonk PC; Tak PP; Boots AH; Baeten D
    Ann Rheum Dis; 2009 Jun; 68(6):1044-50. PubMed ID: 18633128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
    Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
    J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of cleavage of type II collagen by collagenase in osteoarthritis and its progression].
    Kojima T
    Clin Calcium; 2004 Jul; 14(7):90-3. PubMed ID: 15577083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?
    Murphy G; Nagase H
    Nat Clin Pract Rheumatol; 2008 Mar; 4(3):128-35. PubMed ID: 18253109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases.
    Garnero P; Rousseau JC; Delmas PD
    Arthritis Rheum; 2000 May; 43(5):953-68. PubMed ID: 10817547
    [No Abstract]   [Full Text] [Related]  

  • 17. The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial.
    Pullerits R; d'Elia HF; Tarkowski A; Carlsten H
    Rheumatology (Oxford); 2009 Jul; 48(7):785-90. PubMed ID: 19416946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cartilage oligomeric matrix protein as a marker of osteoarthritis.
    Jordan JM
    J Rheumatol Suppl; 2004 Apr; 70():45-9. PubMed ID: 15132354
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential release of molecular markers in joint disease.
    Saxne T
    Acta Orthop Scand Suppl; 1995 Oct; 266():80-3. PubMed ID: 8553866
    [No Abstract]   [Full Text] [Related]  

  • 20. [The biomarker assey for cartilage destruction in rheumatoid arthritis. -Which molecules can reflect cartilage breakdown in RA?-].
    Ishiguro N; Kojima T
    Clin Calcium; 2003 Jun; 13(6):751-4. PubMed ID: 15775147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.